Huang Shao Hui, Lockwood Gina, Irish Jonathan, Ringash Jolie, Cummings Bernard, Waldron John, Kim John, Dawson Laura A, Bayley Andrew, Hope Andrew, O'Sullivan Brian
Radiation Medicine Program, Princess Margaret Hospital, Toronto, ON, Canada.
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1110-5. doi: 10.1016/j.ijrobp.2008.05.021. Epub 2008 Aug 15.
The role of primary radiotherapy (RT) for laryngeal verrucous carcinoma (LVC) is controversial because of concerns about anaplastic transformation, an increased incidence of metastases, and poorer local control after RT. To address these concerns, we report our experience.
All patients with pathologically diagnosed LVC treated with primary RT at our institution between 1961 and 2004 were reviewed. The local control, overall survival, and disease-specific survival rate were established. The outcome after salvage treatment and the incidence of metastases and anaplastic transformation were determined.
Of 62 LVC patients with a minimal follow-up of 2 years, 20 local and 1 nodal recurrence were identified. Salvage surgery was undertaken in 18 of the 21 patients, and disease control was achieved in 17; the eighteenth patient died of a complication after surgery. Ultimate laryngeal preservation was achieved in 50 patients (81%), including 42 after initial RT and an additional 8 after salvage surgery. Distant failure and anaplastic transformation were not observed. Second cancers after RT were identified in 4 patients, only 1 of which was a head-and-neck cancer detected 11 years later. Of the 39 deceased patients, only 3 died of LVC. The local control, overall survival, and disease-specific survival rate at 5 years was 66% (95% confidence interval, 52-77%), 87% (95% confidence interval, 75-93%), and 97% (95% confidence interval, 87-99%), respectively.
The results of our study have shown that the initial control of LVC with RT is less reliable compared with reports from surgical series; however, local recurrence was almost always salvaged successfully, resulting in disease-specific survival rates equivalent to those of surgical series. Neither anaplastic transformation nor unusual metastasis development was observed in this series.
由于担心间变转化、转移发生率增加以及放疗后局部控制较差,原发性放疗(RT)在喉疣状癌(LVC)中的作用存在争议。为解决这些问题,我们报告我们的经验。
回顾了1961年至2004年间在我们机构接受原发性放疗治疗的所有经病理诊断为LVC的患者。确定了局部控制率、总生存率和疾病特异性生存率。确定了挽救治疗后的结果以及转移和间变转化的发生率。
在62例LVC患者中,至少随访2年,发现20例局部复发和1例淋巴结复发。21例患者中有18例接受了挽救性手术,17例实现了疾病控制;第18例患者术后死于并发症。50例患者(81%)最终保留了喉部,其中42例在初始放疗后保留,另外8例在挽救性手术后保留。未观察到远处转移和间变转化。放疗后有4例患者发生了第二原发癌,其中只有1例是11年后检测到的头颈癌。在39例死亡患者中,只有3例死于LVC。5年时的局部控制率、总生存率和疾病特异性生存率分别为66%(95%置信区间,52 - 77%)、87%(95%置信区间,75 - 93%)和97%(95%置信区间,87 - 99%)。
我们的研究结果表明,与手术系列报道相比,放疗对LVC的初始控制不太可靠;然而,局部复发几乎总能成功挽救,导致疾病特异性生存率与手术系列相当。本系列中未观察到间变转化或异常转移的发生。